These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Mitotane treatment for adrenocortical carcinoma: an overview. De Francia S; Ardito A; Daffara F; Zaggia B; Germano A; Berruti A; Di Carlo F Minerva Endocrinol; 2012 Mar; 37(1):9-23. PubMed ID: 22382612 [TBL] [Abstract][Full Text] [Related]
5. What is the best approach to an apparently nonmetastatic adrenocortical carcinoma? Fassnacht M; Allolio B Clin Endocrinol (Oxf); 2010 Nov; 73(5):561-5. PubMed ID: 20738315 [TBL] [Abstract][Full Text] [Related]
16. Systemic treatment of adrenocortical carcinoma in children: data from the German GPOH-MET 97 trial. Redlich A; Boxberger N; Strugala D; Frühwald MC; Leuschner I; Kropf S; Bucsky P; Vorwerk P Klin Padiatr; 2012 Oct; 224(6):366-71. PubMed ID: 23143764 [TBL] [Abstract][Full Text] [Related]
17. Cortisol as a possible marker of metastatic adrenocortical carcinoma: a case report with 3-year follow-up. Schwarte S; Brabant EG; Bastian L; Bruns F Anticancer Res; 2007; 27(4A):1917-20. PubMed ID: 17649795 [TBL] [Abstract][Full Text] [Related]